Anesthesia management using remimazolam for coronary artery bypass grafting and aortic valve replacement in a patient with severe cardiac dysfunction: A case report
Remimazolam, a short-acting benzodiazepine approved for use in general anesthesia in Japan in 2020, has cardiovascular stability superior to conventional anesthetics. Anesthesia management using remimazolam of a patient with impaired cardiac function and several complications is reported. A man in h...
Saved in:
| Main Authors: | Tomoki Sagawa, Yusuke Ishida, Tomomi Sasaki, Maiko Hosokawa, Kiyoko Bito, Katsunori Oe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | SAGE Open Medical Case Reports |
| Online Access: | https://doi.org/10.1177/2050313X241310640 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anesthesia Management Using Remimazolam in A Patient With Bernard‐Soulier Syndrome: A Case Report
by: Tomoharu Shakuo, et al.
Published: (2025-05-01) -
AORTIC VALVE REPLACEMENT IN PATIENT WITH FUNCTIONING CORONARY ARTERY BYPASS GRAFTS
by: M. A. Snegirev, et al.
Published: (2020-03-01) -
Hypotension after induction of anesthesia with remimazolam or etomidate: a non-inferiority randomized controlled trial in patients undergoing coronary artery bypass grafting
by: Jeong-Jin Min, et al.
Published: (2025-06-01) -
Concomitant open aortic valve replacement, ascending aortic replacement, coronary artery bypass grafting and open infrarenal abdominal aortic aneurysm repair
by: Mohammed M. Chowdhury, PhD, FRCS, et al.
Published: (2024-12-01) -
Unfavorable impact of female gender on outcomes following aortic valve replacement combined with coronary artery bypass grafting
by: Bartłomiej Perek, et al.
Published: (2025-05-01)